IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+19.03%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$444M
AUM Growth
+$444M
(-10%)
Cap. Flow
-$53.8M
Cap. Flow
% of AUM
-12.13%
Top 10 Holdings %
Top 10 Hldgs %
35.87%
Holding
93
New
28
Increased
20
Reduced
11
Closed
33
Top Buys
| 1 |
Moderna
MRNA
|
$18M |
| 2 |
Quest Diagnostics
DGX
|
$15.6M |
| 3 |
Cigna
CI
|
$14.9M |
| 4 |
Universal Health Services
UHS
|
$14.1M |
| 5 |
Intuitive Surgical
ISRG
|
$11.7M |
Top Sells
| 1 |
Baxter International
BAX
|
$16.2M |
| 2 |
CRISPR Therapeutics
CRSP
|
$14.4M |
| 3 |
Boston Scientific
BSX
|
$13.6M |
| 4 |
Biogen
BIIB
|
$13.4M |
| 5 |
CVS Health
CVS
|
$12.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$4.23B
| $18.3M | 3.85% | 400,000 +50,000 | +14% | +$2.29M |
|
|
2
Moderna
MRNA
$9.37B
| $18M | 3.77% | +100,000 | New | +$18M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $17.6M | 3.69% | 170,000 +63,000 | +59% | +$6.52M |
|
4
Merck
MRK
$210B
| $16.6M | 3.49% | 150,000 -35,000 | -19% | -$3.88M |
|
|
5
Quest Diagnostics
DGX
$20.3B
| $15.6M | 3.28% | +100,000 | New | +$15.6M |
|
6
Inspire Medical Systems
INSP
$2.77B
| $15.1M | 3.17% | 60,000 +20,000 | +50% | +$5.04M |
|
7
Zentalis Pharmaceuticals
ZNTL
$122M
| $15.1M | 3.17% | 750,000 +200,000 | +36% | +$4.03M |
|
|
8
Cigna
CI
$80.3B
| $14.9M | 3.13% | +45,000 | New | +$14.9M |
|
|
9
Universal Health Services
UHS
$11.6B
| $14.1M | 2.96% | +100,000 | New | +$14.1M |
|
|
SAGE
10
DELISTED
Sage Therapeutics
SAGE
| $13.7M | 2.88% | 360,000 +3,000 | +0.8% | +$114K |
|
11
Exact Sciences
EXAS
$8.98B
| $13.6M | 2.86% | 275,000 +125,000 | +83% | +$6.19M |
|
12
Guardant Health
GH
$8.41B
| $12.9M | 2.71% | 475,000 +25,000 | +6% | +$680K |
|
13
Elevance Health
ELV
$71.8B
| $12.8M | 2.69% | 25,000 -15,000 | -38% | -$7.69M |
|
14
uniQure
QURE
$896M
| $12.5M | 2.62% | 550,000 +117,000 | +27% | +$2.65M |
|
|
15
Intuitive Surgical
ISRG
$170B
| $11.7M | 2.45% | +44,000 | New | +$11.7M |
|
16
HCA Healthcare
HCA
$94.5B
| $10.3M | 2.17% | +43,000 | New | +$10.3M |
|
17
Gilead Sciences
GILD
$140B
| $10.3M | 2.16% | +120,000 | New | +$10.3M |
|
18
Sanofi
SNY
$121B
| $9.69M | 2.03% | 200,000 -50,000 | -20% | -$2.42M |
|
19
AstraZeneca
AZN
$248B
| $9.49M | 1.99% | +140,000 | New | +$9.49M |
|
20
Relay Therapeutics
RLAY
$619M
| $9.34M | 1.96% | 625,000 +25,000 | +4% | +$374K |
|
21
Krystal Biotech
KRYS
$4.27B
| $9.11M | 1.91% | 115,000 +25,000 | +28% | +$1.98M |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $8.32M | 1.75% | 35,000 -35,000 | -50% | -$8.32M |
|
23
Zimmer Biomet
ZBH
$21B
| $8.29M | 1.74% | +65,000 | New | +$8.29M |
|
24
Centene
CNC
$14.3B
| $8.2M | 1.72% | 100,000 -125,000 | -56% | -$10.3M |
|
25
AbbVie
ABBV
$372B
| $8.08M | 1.7% | +50,000 | New | +$8.08M |
|